We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

MPI Research Continues Toxicology Expansion

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

As part of a series of planned expansions, MPI Research announced the immediate availability of additional toxicology capacity. Through its portfolio of services the company generates critical safety data for the pharmaceutical and biotechnology industries prior to a new drug candidate’s introduction to humans.

Completed July 20th, the 79,000 square foot toxicology expansion project includes the addition of 84 animal rooms, new surgical suites and accommodations for specialized infusion work.

The project is part of a multi-phased expansion plan fueled by the growing research and development needs of the pharmaceutical and biotechnology industries. In 2006, the company completed toxicology expansion projects totaling $65 million, including 95 animal rooms plus significant laboratory and office space.

“Our expansion projects are driven by our customers’ need for timely, cost effective research and development services,” said Bill Parfet, Chairman and Chief Executive Officer of MPI Research. “Our ongoing investments in capacity, service expansions and infrastructure will further assure our customers of timely study starts, quality services, and on-time reporting to keep their drug development programs moving forward.”